Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system

Esthesioneuroblastoma is a sinonasal tumor with distinct clinicopathologic features, multiple facets, and a spectrum of behavior. Characterization of this disease is challenging, and clinically, several staging systems have been used with no consensus on a single scheme. Recently, the Hyams histolog...

Full description

Saved in:
Bibliographic Details
Main Author: Saade, Rami E. (author)
Other Authors: Hanna, Ehab Y. (author), Bell, Diana (author)
Format: article
Published: 2015
Online Access:http://hdl.handle.net/10725/6151
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/41427
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Esthesioneuroblastoma is a sinonasal tumor with distinct clinicopathologic features, multiple facets, and a spectrum of behavior. Characterization of this disease is challenging, and clinically, several staging systems have been used with no consensus on a single scheme. Recently, the Hyams histological grading system has emerged as a promising prognostication tool that offers an added value to stage. This review addresses prognosis and biology in esthesioneuroblastoma. More specifically, we sought to present a critical appraisal on the value of each of these stratification systems, stage vs. grade, in identifying risk groups and guiding management.